These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
371 related items for PubMed ID: 17570067
1. Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline. Balarini Lima GA, Machado Ede O, Dos Santos Silva CM, Filho PN, Gadelha MR. Pituitary; 2008; 11(3):287-92. PubMed ID: 17570067 [Abstract] [Full Text] [Related]
2. Pituitary apoplexy associated with cabergoline therapy. Chng E, Dalan R. J Clin Neurosci; 2013 Dec; 20(12):1637-43. PubMed ID: 24113159 [Abstract] [Full Text] [Related]
7. Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine. Delgrange E, Maiter D, Donckier J. Eur J Endocrinol; 1996 Apr; 134(4):454-6. PubMed ID: 8640297 [Abstract] [Full Text] [Related]
13. Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma. Dhanwal DK, Sharma AK. Pituitary; 2011 Dec; 14(4):384-7. PubMed ID: 19381817 [Abstract] [Full Text] [Related]
14. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. Ono M, Miki N, Amano K, Kawamata T, Seki T, Makino R, Takano K, Izumi S, Okada Y, Hori T. J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175 [Abstract] [Full Text] [Related]
15. [Cabergoline-induced tension pneumocephalus in a patient with giant invasive prolactinoma. Case report]. Castro-Castro J, Torre-Eiriz JA, Pinzón-Millán A, Pastor-Zapata A. Neurocirugia (Astur); 2011 Dec; 22(6):558-61; discussion 561. PubMed ID: 22167286 [Abstract] [Full Text] [Related]